Corona virus: Finally Treatment Found, FDA Approves chloroquine
The American Food and Drug Administration on Sunday (FDA) issued an emergency-use authorization for a pair of anti-malaria drugs as health officials’ work to combat the rapid spread of the novel coronavirus.
The Health and Human Services Department (HHS) said in a statement that the authorization would allow 30 million doses of hydroxyl chloroquine sulfate and 1 million doses of chloroquine phosphate to be donated to the Strategic National Stockpile. see https://myeduproject.com.ng/coronavirusiranian-backed-militias-in-syria-are-getting-hit-hard-by-the-virus
The doses of hydroxychloroquine sulfate were donated by Sandoz, while the chloroquine phosphate was developed by Bayer Pharmaceuticals.
The products will be “((distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible)),” HHS said. see https://myeduproject.com.ng/coronavirus-buharis-daughter-on-self-isolation-after-return-from-uk
President Trump has repeatedly touted the anti-malaria drugs as a possible coronavirus “game changer,” despite warnings from health officials that not enough is known about their effects on COVID-19.
Dr. Anthony Fauci, the government’s top infectious disease expert, said during a press briefing earlier this month that much of what is known about the drug is based on “anecdotal reports.”
Anti-Malaria Drug-Chloroquine, Approved as compassionate Coronavirus Treatment
The American Food and Drug Administration has approved the use of chloroquine and hydroxychloroquine, drugs used to treat malaria and severe arthritis, as a compassionate Coronavirus Treatment
In a press briefing on Thursday, United State president, Donald Trump disclosed the success using chloroquine and hydroxychloroquine as a compassionate treatment for Coronavirus
At the moment, chloroquine and hydroxychloroquine are undergoing clinical trial by the Food and Drug Administration to ascertain the efficacy and potency of this claim. Trump also said that other antiviral medications will be fast-tracked for FDA approval.
In his correct and precise word, Trump added that the FDA approved “compassionate use” for a number of patients, which allows very ill patients to use drugs not yet approved by the agency for widespread use.